StockLens

NATCOPHARM vs GRANULES vs BIOCON vs ALKEM: which stock is better?

Granules India Limited (GRANULES) has the highest StockLens rating in this group at 7.5/10 (Good).

MetricNATCOPHARMGRANULESBIOCONALKEM
Overall rating6.2/10 (Average)7.5/10 (Good)2.4/10 (Poor)5.7/10 (Average)
Long-term viewNeutral (watchlist)Strong long-term candidateAvoidNeutral (watchlist)
Trade biasStrong shortStrong longStrong shortStrong short
Share price₹822.90₹815.50₹359.40₹5,175.00
Market cap₹16,143 Cr₹22,245 Cr₹58,861 Cr₹61,875 Cr
P/E17.928.5120.629.9
Return on equity–13.5%1.0%14.2%
Debt / equity0.080.170.420.15
Revenue growth (YoY)-44.7%+20.3%+2.2%+13.8%
1-year return+3.0%+47.0%-6.0%-8.7%

Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.